DANA PEACHEY: Open Payments
NPI 1699720383 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 23 payments from 12 companies in 2025. Trend: 2023 $1,309 · 2024 $1,345 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 2 | $96 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Medtronic, Inc. | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| PFIZER INC. | 2 | $54 |
| Novo Nordisk Inc | 2 | $50 |
| Boston Scientific Corporation | 2 | $42 |
| Lilly USA, LLC | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Impulse Dynamics (USA) Inc. | 1 | $21 |
Products named: Attruby, CAMZYOS, LEQVIO, VYNDAQEL, Wegovy, General - Therapies, COREVALVE EVOLUT R, PULSESELECT.
Industry payments across ID — which companies pay providers there.
